Figure 5.
Cell viability of PC12 cells treated with Aβ1–42 and PhGs. #P<0.05, vs. control group; *P<0.05, vs. model group. Aβ, â-amyloid peptide; PhGs, phenylethanoid glycosides.
Cell viability of PC12 cells treated with Aβ1–42 and PhGs. #P<0.05, vs. control group; *P<0.05, vs. model group. Aβ, â-amyloid peptide; PhGs, phenylethanoid glycosides.